Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	1.57B
Revenue (ttm)	196.12M
Net Income (ttm)	-50.85M
Shares Out	99.34M
EPS (ttm)	-0.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	292,398
Average Volume	319,986
Open	16.00
Previous Close	15.82
Day's Range	15.32 - 16.00
52-Week Range	6.65 - 25.40
Beta	0.90
RSI	64.20
Earnings Date	Jul 18, 2025

About CrossFirst Bankshares

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 109
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2024, Sedana Medical AB's revenue was 178.75 million, an increase of 16.17% compared to the previous year's 153.87 million. Losses were -10.67 million, -82.09% less than in 2023.